Who we are
On By discovering, developing and delivering innovative medicines to fight against diseases. We aim to improve human health and increase the quality of longevity.
Medzym is an early stage, stealth mode, a longevity-biotech entity that is through R&D discovering and developing products for the aging population in the areas of eye diseases such as Glaucoma, Age-related Macular Degeneration (AMD), Cataracts, and Eye-allergy.
This purpose has guided us to become an innovative force in the molecular medicines. The company’s scientific and management credibility is well recognized. Team’s credibility further manifests itself in a twenty-year history of being committed to life-threatening disease research.
Our approach
New Innovation for vision
Medzym is in the process of developing formulations of ocular solutions for eye diseases and their prevention. Medzym’s technology presents the first major leap forward in the treatment and possible prevention of Glaucoma. This drug candidate can be used topically. Preliminary (fast and crude experiments) indicate that the primary component in the formulation is active and well characterized. The formulation is expected to be non-toxic under natural physiological conditions. The primary compound is stable at room temperature for more than one month.
Old Drugs Made New for Eye Diseases
The eyes are among the most readily accessible organs in terms of location in the body, yet drug delivery to eye tissues is particularly problematic. Poor bioavailability of drugs from ocular dosage forms is mainly due to precorneal loss factors. There is a clear need for effective topical formulations capable of promoting drug penetration and maintaining therapeutic levels with a reasonable frequency of application—a strategy that can also result in exacerbation of side effects, which would not be acceptable.
At Medzym we have developed a drug delivery technology based on Nano-Molecular Science (NMS). Delivery of a drug via an NMS-based product may be a good start to fulfill the main objective: enhancement of drug permeation. Our NMS technology provides a unique formulation and an effective solution to the current problems.